跳至主要内容
临床试验/NCT03974711
NCT03974711已完成不适用

Rampart Duo Clinical (RaDical) Study: An Exempt Minimal Risk Post-Market Evaluation of Clinical Outcomes

Spineology, Inc10 个研究点 分布在 1 个国家目标入组 197 人开始时间: 2017年10月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
197
试验地点
10
主要终点
Short-term objective 1: New onset of thigh symptoms -- Anterior Thigh Pain Change from Baseline

研究概览

简要总结

This exempt, minimal risk, prospective, post-market, registry, multi-center, Institution Review Board (IRB) approved observational clinical evaluation was conducted at 10 centers. A total of 197 patients were enrolled. The evaluation collected data in a real-world patient population and was a data collection initiative only. No patient treatments or care were performed as a component of the protocol. All patient care received was on-label and standard of care for lateral lumbar interbody fusions. The data collected in this evaluation is intended to contribute to the body of literature for lateral lumbar interbody fusions.

详细描述

The purpose of this study was to collect data that reports on the clinical outcomes of patients that were treated with the Spineology Rampart DUO device in a standard of care instrumented lateral lumbar interbody fusion procedure at one or two contiguous levels from L2-L5. Data was collected prospectively at specified time points per protocol and included both objective and subjective measures. The study concluded when the final patient achieved their 12-month evaluation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A clinical decision has been made to treat the patient with the Rampart Duo Interbody Spacer prior to enrollment into this research evaluation. This decision is independent (made outside) of the decision to take part in the research.

排除标准

  • Previous interbody fusion or total disc replacement at the index level(s).
  • Enrolled in a concurrent clinical investigation that may confound the findings of the present investigation.

结局指标

主要结局

Short-term objective 1: New onset of thigh symptoms -- Anterior Thigh Pain Change from Baseline

时间窗: 3 months

Change from Baseline anterior thigh pain score through 3-months. Pain assessment captured on 100 mm VAS. A higher VAS score represents a worsening of pain.

Short-term objective 1: New onset of thigh symptoms -- Thigh Neurological Change from Baseline

时间窗: 3 months

Change from baseline in anterior thigh neurological assessment through 3 months. Anterior Thigh Neurological deficit defined as a negative change in strength (hip/flexor weakness) or sensation (anterior thigh).

Long-term objective 1: Patient Low back pain change over time

时间窗: Through 12 months postoperative.

Pain measured on 100 mm VAS and compared to baseline.

Short-term objective 2: Hospital economics -- Blood Loss

时间窗: EBL collected at time of surgery.

Estimated blood loss (EBL) shall be compared to published literature.

Short-term objective 2: Hospital economics -- Duration of Surgery

时间窗: DoS collected at time of surgery.

Duration of surgery (DoS) defined as time from incision to closure shall be compared to published literature.

Short-term objective 2: Hospital economics -- Time-to-Discharge

时间窗: Perioperative.

Time-to-discharge (TTD) defined as time from hospital admission to the time the subject is discharged from the hospital and it shall be compared to published literature.

Long-term objective 1: Patient Low back function change over time

时间窗: Through 12 months postoperative.

Low back function determined on Oswestry Disability Index (ODI) and compared to baseline.

次要结局

  • Additional Outcomes 1 - Radiographic Assessments(Assessed at 12 months postoperative.)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验

Rampart Duo Clinical (RaDical) Post-Market Study | 临床试验